Description du projet
Développer la recherche sur le cancer au Portugal
Le cancer est l’une des principales causes de décès dans le monde et, malgré des recherches intensives, de nombreux aspects concernant la biologie du cancer et les métastases demeurent obscurs. Comprendre les mécanismes impliqués dans la progression des tumeurs, la résistance et les rechutes est essentiel à la conception de nouvelles thérapies. Le projet QuantOCancer, financé par l’UE, entend renforcer la capacité de la Fondation Champalimaud, au Portugal, à mener des recherches génétiques, de modélisation, d’imagerie et quantitatives axées sur le cancer. Le programme de recherche reliera et transformera les différentes opérations de recherche de la Fondation. Des opportunités de formation et de mise en réseau à l’étranger renforceront le potentiel et l’excellence de la recherche.
Objectif
The QuantOCancer project aims to attract and maintain an outstanding researcher and research manager to incept the quantitative biomedicine research programme focused on cancer at the Champalimaud Foundation (CF) that will allow consolidating and expanding CF’s internationally-leading position as a biomedical research excellence centre with a unique organismic approach to health and disease that smoothly integrates theoretical and experimental conceptual frameworks. The ERA Chair will: i) bring the needed critical mass to the recently created Biology of Systems and Metastasis research programme through the inception of a truly multidisciplinary and intersectoral research field; ii) effectively cement the CF Research Programme, by leveraging the installed research capacity in quantitative biomedicine; iii) root an effective bridge between research excellence and clinical practice at CF, through the creation of an innovative MD/PhD programme. The attractiveness of the CF as well as of the Lisbon region and the country will be fully unlocked through the implementation of an additional set of measures including: 1)institutional changes, aiming, among others, to further explore the installed R&T capacity; 2) capacity building activities, including the expansion of the advanced training opportunities to the postdoctoral community; and 3) intersectoral and international networking activities, open to external stakeholders, with a strong focus on the interface between EU and overseas opportunities. These will allow incepting and spreading a RRI culture in line with the ERA priorities as well as to endeavour EU and overseas collaborative efforts towards a truly open and international R&I global ecosystem. Trough QuantOCancer CF will boost its capacity to retain internationally competitive research funding in this way effectively contributing to the achievement of the regional and national smart specialisation goals and as such to reduce the EU disparities in R&I performance.
Champ scientifique
Programme(s)
- H2020-EU.4.c. - Establishing ‚ERA Chairs’ Main Programme
Thème(s)
Appel à propositions
Voir d’autres projets de cet appelSous appel
H2020-WIDESPREAD-03-2017-ERAChairs
Régime de financement
CSA - Coordination and support actionCoordinateur
1400-038 Lisboa
Portugal